Cartesian Therapeutics, Inc.
RNAC
$8.52
-$0.18-2.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.68% | -157.86% | -326.00% | 189.70% | -72.73% |
| Total Depreciation and Amortization | 1.15% | 0.33% | 2.89% | -49.05% | 137.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.96% | 287.45% | 158.99% | -6,253.03% | 112.93% |
| Change in Net Operating Assets | 2,366.67% | -100.57% | 135.15% | 78.71% | -203.43% |
| Cash from Operations | -24.97% | -13.54% | 10.96% | 24.18% | -230.02% |
| Capital Expenditure | 94.51% | 61.92% | 50.21% | -141.40% | -52.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.51% | 61.92% | 50.21% | -141.40% | -203.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 458.00% | 900.00% | -94.12% | -53.55% | -78.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15,190.20% | -137.21% | -72.00% | 99.70% | -12,336.36% |
| Cash from Financing | 30,236.54% | -36.84% | -163.33% | 100.75% | -1,124.90% |
| Foreign Exchange rate Adjustments | -163.64% | 210.00% | -183.33% | -62.50% | 313.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.38% | -7.70% | 15.49% | 37.71% | -388.40% |